Six notes:
1. Aurora Spine saw $4 million in first-quarter sales, a 35.7% increase from the same time in 2023.
2. The company saw a gross margin of 61.9%. That was a 10.2% increase year-over-year.
3. Sales of the SiLO-TFX sacroiliac joint implant and SiLo allograft implant made up 35.2% of quarterly sales.
4. The Zip 51 implant saw $544,190 in sales, an increase of 193% year-over-year.
5. Operating expenses in the first quarter were $2.75 million compared to $2.19 million in the first quarter of 2023.
6. Aurora Spine saw a net loss of $267,000 in the first quarter.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
